Tactile Systems Technology Inc
NASDAQ:TCMD

Watchlist Manager
Tactile Systems Technology Inc Logo
Tactile Systems Technology Inc
NASDAQ:TCMD
Watchlist
Price: 28.72 USD 1.66% Market Closed
Market Cap: $641.6m

Tactile Systems Technology Inc
Other Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Tactile Systems Technology Inc
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Items CAGR 3Y CAGR 5Y CAGR 10Y
Tactile Systems Technology Inc
NASDAQ:TCMD
Other Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Other Items
-$442m
CAGR 3-Years
38%
CAGR 5-Years
4%
CAGR 10-Years
25%
Boston Scientific Corp
NYSE:BSX
Other Items
-$5B
CAGR 3-Years
-52%
CAGR 5-Years
N/A
CAGR 10-Years
-12%
Stryker Corp
NYSE:SYK
Other Items
-$4.1B
CAGR 3-Years
-21%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Abbott Laboratories
NYSE:ABT
Other Items
-$173m
CAGR 3-Years
N/A
CAGR 5-Years
-35%
CAGR 10-Years
N/A
Intuitive Surgical Inc
NASDAQ:ISRG
Other Items
$1.2B
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Tactile Systems Technology Inc
Glance View

Market Cap
641.6m USD
Industry
Health Care

Tactile Systems Technology, Inc. is a medical technology company. The company is headquartered in Minneapolis, Minnesota and currently employs 988 full-time employees. The company went IPO on 2016-07-28. Its therapeutic focus is vascular disease, for treating lymphedema and chronic venous insufficiency. The company is a manufacturer and distributor of the Flexitouch and Entre systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition. Its at-home Flexitouch system provides automated, at-home lymphatic drainage therapy. Its Flexitouch Plus system is an automated, programmable, pneumatic compression device (APCD), designed for the treatment of lymphedema in the home setting. Its Entre system is a pneumatic compression device used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company possesses a platform to deliver at-home healthcare solutions directly to patients throughout the United States.

TCMD Intrinsic Value
HIDDEN
Show

See Also

Back to Top